Fusicoccin-A Targets Cancerous Inhibitor of Protein Phosphatase 2A by Stabilizing a C-Terminal Interaction with 14-3-3-Reference-Cited by-同舟云学术

Fusicoccin-A Targets Cancerous Inhibitor of Protein Phosphatase 2A by Stabilizing a C-Terminal Interaction with 14-3-3

Published:2022-10-18 Issue:11 Volume:17 Page:2972-2978
ISSN:1554-8929
Container-title:ACS Chemical Biology
language:en
Short-container-title:ACS Chem. Biol.

Author:

Brink Hendrik J.¹^ORCID,van Senten Jeffrey R.¹,De Vries-van Leeuwen Ingrid J.¹,da Costa Pereira Daniel¹,Piersma Sander R.²,Jimenez Connie R.²,Centorrino Federica³,Ottmann Christian³^ORCID,Siderius Marco¹,Smit Martine J.¹^ORCID,de Boer Albertus H.¹

Affiliation:

1. Amsterdam Institute for Molecular and Life Sciences (AIMMS), Division of Medicinal Chemistry, Faculty of Sciences, Vrije Universiteit, De Boelelaan 1108, Amsterdam 1081 HZ, The Netherlands

2. OncoProteomics Laboratory, Department of Medical Oncology, Amsterdam University Medical Center (VUmc), 1081 HV Amsterdam, The Netherlands

3. Laboratory of Chemical Biology, Department of Biomedical Engineering and Institute for Complex Molecular Systems (ICMS), Eindhoven University of Technology, 5600 MB Eindhoven, The Netherlands

Funder

Vrije Universiteit Amsterdam

Amsterdam Institute of Molecules, Medicines and Systems

Publisher

American Chemical Society (ACS)

Subject

Molecular Medicine,General Medicine,Biochemistry

Link

https://pubs.acs.org/doi/pdf/10.1021/acschembio.2c00299

Reference27 articles.

1. Cancer statistics, 2019

2. Clinical significance of cancerous inhibitor of protein phosphatase 2A in human cancers